Researchers from Yale-NUS College have partnered with researchers from the National University of Singapore (NUS) and SingHealth Group to develop a novel Caenorhabditis elegans (C. elegans) worm strain which expresses an amyloid beta protein fragment involved in the development of human Alzheimer’s Disease (AD). This strain will serve as a tool for the testing of interventions against AD and to help researchers understand the disease better.
from Dementia Big http://ift.tt/2dSpfme via alcoholic dementia
http://ift.tt/2ffDLWQ
No comments:
Post a Comment